KYPROLIS® (carfilzomib) is a treatment option for people who have already received 1 or more previous treatments for relapsed multiple myeloma. If you have question, please e-mail Allevaire Indian Team or call Allevaire Network on +91-9818274099 (Mr. Kamal Kaushal) for further details.
KYPROLIS ( Carfilzomib ) Injection is a proteasome inhibitor indicated for the treatment of patients with. multiple myeloma who have received at least two prior therapies including. bortezomib and an immunomodulatory agent and have demonstrated disease. progression on or within 60 days of completion of the last therapy.
KYPROLIS (Carfilzomib) Injection suppliers in India. Allevaire India Network New Delhi, INDIA.
Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.
ALLEVIARE LIFE SCIENCES connects the buyer with the supplier who can ship Kyprolis (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. Kyprolis is manufactured by Onyx Pharmaceuticals.
Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
The order for KYPROLIS (Carfilzomib) Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Kyprolis is indicated in combination with dexamethasone or with lenalidomide plus dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy.
Kyprolis is indicated as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy.
Medicine Name: Kyprolis
Generic Name: Carfilzomib
Approval Date: 20.07.2012.
Available as (Form & Strength): Administer intravenously over 2 to 10 minutes, on two consecutive days each
week for three weeks (Days 1, 2, 8, 9, 15, and 16), followed by a 12-day rest
period (Days 17 to 28).
Company Name: Onyx Pharmaceuticals.
Please contact +91 9818274099 for KYPROLIS( Carfilzomib ) price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Supplied: KYPROLIS (carfilzomib) for Injection is supplied as an individual carton single-use vial containing a dose of 60 mg of carfilzomib as a white to off-white lyophilized cake or powder. Â• NDC 76075-101-01, 60 mg carfilzomib per vial.
Storage and Handling: Unopened vials should be stored refrigerated (2Â°C to 8Â°C; 36Â°F to 46Â°F). Retain in original package to protect from light.
KYPROLIS should not be taken alone.
It is not known if KYPROLIS is safe and effective in children under 18 years of age.
KYPROLIS (Carfilzomib) is available.
Get In Touch
ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand KYPROLIS (Carfilzomib) Injection on prescription and Import License in Patient’s Name only.
For foreign countries patients, KYPROLIS (Carfilzomib) Injection can be made available in Send your inquiry to find KYPROLIS (Carfilzomib) Injection in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For KYPROLIS (Carfilzomib) Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details